U.S. Health-Care Vote News Monitoring

BMJD has further enhanced the format of its program for 2019 with new approaches to yet more productive interactions and discussions between experts and participants, offering the best possible translational learning experience while sharing the most recent advances in the treatment and investigation of a number of musculoskeletal diseases. The 2019 program will focus on the most challenging arthritic conditions seen in daily practice both in Asia and in the rest of the world. The aims will be to help physicians by improving the investigation and management of patients suffering from these diseases. Expert debates on the many advancements in the clinical and basic science fields of bone, muscle and joint diseases will focus on providing practical management solutions to challenging and ...

The program will highlight the diagnosis and management of cardiac arrhythmias which can present as medical emergencies where immediate treatment is needed. Faculty will provide comprehensive updates on the diagnosis, treatment and management in atrial fibrillation. Contributing factors to the onset of atrial fibrillation and anticoagulation management options will be reviewed. Faculty will share “pearls” to aid in the evaluation and assessment of patients seen in daily practice. Program Highlights: -Understanding the Mechanism of Atrial -Anticoagulation for Atrial -Unusual Contributors to Atrial -Treatment of Atrial -Atrial Fibrillation and Heart -Cryptogenic -Left Atrial Appendage -Atrial Fibrillation and ...

The anterior approach for total hip replacement is an important surgical alternative to the traditional hip replacement protocol: The approach is tissue-sparing and results in less pain, faster patient recovery, and improved mobility related to the lesser trauma provided by the procedure. The 8th Annual Direct Anterior Approach Hip Course will offer a thorough education on the surgical and patient processes associated with the anterior hip approach, from patient selection through patient recovery and follow-up. This course is intended for surgeons already using this procedure and are interested in honing their skills. It will be taught by some of the most well-regarded orthopaedic surgeons practicing today. With didactic presentations, video vignettes, and case-based panel discussions, ...

Sponsors often take for granted the fact that early phase trial design and operations can make or break future studies. When hard data is severely limited and is used to predict well beyond its boundaries, the quality of that data is absolutely paramount. The data obtained from phase 1 first-in-human studies through phase 2 proof-of-concept and dose range finding studies are vital to effectively designing future registration studies. Early phase clinical trials should be safe experiments on humans, not small-scale phase 3 trials. Therefore, it is beneficial to intelligently optimize early phase clinical activity to ensure successful trial execution and regulatory approval. TOP FIVE REASONS TO *Implement adaptive study designs and predictive models to successfully accelerate early ...

USE CODE "EVENT50" for $50 off registration! For 24 years, this premier gathering of healthcare professionals involved in the treatment of lung cancer continues to differentiate itself from other meetings in the field of thoracic oncology by offering a broad scope of topics essential for practicing oncologists and clinicians. The conference offers a comprehensive update on lung cancer screening and smoking cessation, biomarker testing, management of lung cancer across the spectrum of disease stages, and NSCLC, SCLC, mesothelioma, and thoracic tumors. This activity is designed to meet the educational needs of all healthcare professionals interested in the care and treatment of patients with thoracic malignancies.

Call for Abstracts & Proposals Submission: EUSTM-2019 cordially invites researchers, investigators & clinicians from various specialties as well as industry professionals to submit abstracts in all areas outlined under conference tracks: Benchside Track: Cellular Biology/Molecular Biology Pathophysiology/Molecular Medicine Drug discovery and development Omics sciences Data mining & Management Biomarkers Others Bedside Track: Clinical Case Reports Clinical Trials Clinical Studies Others Preventive Medicine Track: Vaccines Public Health Health Promotion Clinical Epidemiology Others Call for Sessions/Symposia/Workshops/Panel Discussion Proposals: EUSTM-2019 congress committee will consider both non-commercial & commercially oriented ...

TACA (The Autism Community in Action) is a non-profit organization that provides education, support, and hope to families living with autism since 2000 and strives to help every individual diagnosed with autism lead an independent life. For more information about TACA, please visit www.tacanow.org/conference/west-coast/. By attending one or both of these workshops, practitioners will also receive free admission to The National TACA Autism Conference, October 18-20, 2019. Practitioners who attend the workshops are not required to attend the TACA Conference. CME available! Attendees receive one FREE Organic Acids Test (OAT), worth $299! Day 1 | Friday, October ORGANIC ACIDS Learn how to use this comprehensive metabolic test in your practice to help with your most difficult-to-...

The 47th Annual Meeting of the International Society for Pediatric Neurosurgery (ISPN), which will be held in Birmingham on 20-24 October 2019 will offer a top scientific program with the contributions from world-renowned scientists specialized in Pediatric Neurosurgery. The scientific program will bring together leading international experts to discuss breakthroughs in pediatric neurosurgery, advances in clinical practice and to gain comprehensive knowledge and skills in intraoperative monitoring among other topics. Starting from our Nursing Symposia, pre-congress meetings to the end of the Congress, get ready for the latest news in our ever-growing field. - Abstract Submission Deadline: 1 April - Early Registration Deadline: 29 August There is no better place than Birmingham,...

The event will explore how the latest technologies can benefit HPAPI with artificial intelligence and machine learning to hasten risk assessment and validation. We will also be dedicating much deserved attention on emerging therapies including bispecific antibodies, oncolytic viral complexes and hormones. Will the super-high level 5 banding for these biologics prove effective or inept? Are current containment planning and solutions truly ensuing the health of workers? Come and find the answers to these hot topics along with the other unique insights such as continuous manufacturing technologies.